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Background
A diagnosis of a second primary breast cancer (‘bilateral
breast cancer’) occurs in between 2-11% of women
affected by breast cancer in the general population, but
is increased in frequency in women with a family history
of breast cancer. We investigated whether the common
genomic variants described in breast cancer GWAS stu-
dies were determinants of the risk of bilateral breast
cancer and compared the effect to that of family history.
Methods
The Victorian FCC Translational Breast Cancer Cohort
consists of the index cases of 1374 families with a high
risk family history of breast or ovarian cancer. The
cohort has been extensively characterised, including
detailed personal and family history and has undergone
genetic testing for both high penetrance genes and low
penetrance variants associated with breast cancer. 1143
women in the cohort have had at least one breast cancer
and 208 women have had multiple primary breast can-
cers. For this study genotypic data from 22 common
genomic variants (SNPs) previously identified in breast
cancer GWAS were analysed for each index case and
compared to the same set of genotypes from an Austra-
lian population based control group (n=895, recruited
from the electoral role for the AOCS). A Polygenic Risk
Score (PRS) was calculated using a multiplicative model
as the sum of the log odds ratios associated with each
allele. Unilateral and bilateral cases were compared on
the basis of both the measured polygenic risk and family
history parameters.
Results
768 women affected by breast cancer were identified in
whom BRCA1 or 2 mutation was excluded by sequen-
cing and MLPA. The cohort was followed up an average
of 8.8 years since their diagnosis of breast cancer with
135 (18%) women having a diagnosis of a second pri-
mary breast cancer. The average Polygenic Risk Score in
the group was 1.30 (Log OR) but was significantly
increased in the women with a history of bilateral versus
unilateral breast cancer (1.40 vs 1.28 p=0.018), with no
difference between the groups in follow up (or time to
cancer diagnosis) (7.3 vs 7.8 years, p=0.50) or age of
first diagnosis (44.8 vs 45.5, p=0.47). Measures of the
family history including the number of breast cancers in
first degree or any relatives, family history of bilateral
breast cancer, male breast cancer or ovarian cancer
were also examined but showed no significant differ-
ences between women with unilateral or bilateral breast
cancer.
To examine the clinical significance of the difference
in PRS the cohort was divided into high, intermediate
and low polygenic risk groups. The OR for bilateral
breast cancer between the high and low risk groups was
1.9 (95% CI 1.07-3.49, p=0.027) and survival analysis
showed a significantly increased rate of second primary
breast cancer in the high versus low polygenic risk
group (cumulative hazard to 20 years of 0.39 vs 0.24).
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Analysis of polygenic risk, determined by common
genomic variants, has the potential to stratify women
affected by familial breast cancer in relation to their risk
of second primary breast cancer, independent of mea-
sures of family history.
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